Sangamo Therapeutics, Inc. (SGMO)
0.366
-0.04
(-8.82%)
USD |
NASDAQ |
Jan 20, 16:00
0.375
+0.01
(+2.46%)
After-Hours: 20:00
Sangamo Therapeutics Market Cap: 123.16M for Jan. 20, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Arcturus Therapeutics Holdings, Inc. | 201.73M |
| AIM ImmunoTech, Inc. | 3.471M |
| Perspective Therapeutics, Inc. | 180.64M |
| Protalix Biotherapeutics, Inc. | 164.86M |
| Armata Pharmaceuticals, Inc. | 214.71M |
Market Cap Related Metrics
| PS Ratio | 2.760 |
| Price to Book Value | 19.72 |
| Price | 0.366 |
| Earnings Yield | -121.0% |